Chronic Kidney Disease in Older Adults. Consensus Statement of  Russian Association of  Gerontologists and Geriatricians, Scientific Society of  Nephrologists of  Russia and Eurasian Association of Therapists

Author:

Tkacheva O. N.1ORCID,Kotovskaya Yu. V.1ORCID,Bobkova I. N.2ORCID,Shutov A. M.3ORCID,Villevalde S. V.4ORCID,Efremova E. V.3ORCID,Runikhina N. K.1ORCID,Eruslanova K. A.1ORCID,Arutyunov G. P.5ORCID,Batyushin M. M.6ORCID,Frolova E. V.7ORCID

Affiliation:

1. Pirogov National Research Medical University, Russian Gerontology Research and Clinical Centre

2. Tareev Rheumatology, Nephrology and Occupational Pathology Clinic, University Clinical Hospital No. 3

3. Ulyanovsk State University

4. Almazov National Medical Research Centre

5. Pirogov National Research Medical University

6. Rostov State Medical University

7. The North-Western State medical University named after I.I. Mechnikov

Abstract

The prevalence of  chronic kidney disease (CKD) increases with age, but CKD is  often underdiagnosed in  older adults and regarded as  age-related changes of  kidney function. Screening for CKD is  mandatory in  older adults and should include estimated glomerular filtration rate (eGFR) using both the CKD EPI creatinine-based formula and the albumin/creatinine ratio in a urine spot sample. In older adults the diagnostic criteria of CKD are the same as in younger subjects.  CKD is  associated with advanced ageing and requires careful assessment of  geriatric syndromes.  Renal function should be assessed at least annually, considering a rate of decline in eGFR greater than 1 ml/min/1.73 m2 per year as significant. Older adults with CKD are characterized by high comorbidity; risk factors for CKD and geriatric syndromes overlap. CKD should be  considered among a  number of  comorbid conditions that increase the risk of  deterioration of  geriatric status and underline the need for multidisciplinary management based on a comprehensive geriatric assessment. Patients with eGFR <60 ml/min/1.73 m2 should be considered at high risk for renal and extrarenal adverse drug effects. In these patients, inappropriate medications, supplements, and vitamins should be carefully identified and corrected using STOPP/START criteria. eGFR and estimated creatinine clearance should be  carefully monitored during treatment with drugs that can potentially affect renal function and/or the dose of which is adjusted based on renal function, as well as during acute illness or exacerbation of chronic conditions.

Publisher

Autonomous non-profit organization-Society of Specialists in the Field Innovative Medical Technology

Reference48 articles.

1. Клинические рекомендации «Хроническая болезнь почек», https://cr.minzdrav.gov.ru/recomend/469_2

2. Moiseev V.C., Mukhin N.A., Smirnov A.V., Kobalava J.D., Bobkova I.N., Villevalde S.V., Yefremovtseva M.A., Kozlovskaya L.V., Shvetsov M.Yu., Shestakova M.V., Arutyunov G.P., Boytsov S.A., Galyavich A.S., Greenstein Y.I., Dobronravov V.A., Drapkina O.M., Ermolenko V.M., Karpov Yu.A., Kayukov I.G., Kotovsky J.V., Kukharchuk V.V., Martynov A.I., Morozova T.E., Oganov R.G., Podzolkov V.I., Rozhinskaya L.Y., Tereshchenko S.N., Fomin V.V., Khirmanov V.N., Chazova I.E., Shamkhalova M.S., Shilov E.M., Shlyakhto E.V., Shutov A.M. Cardiovascular risk and chronic kidney disease: cardio-nephroprotection strategies. Russian Journal of Cardiology. 2014;(8):7-37. (In Russ.)

3. de Boer IH. Chronic kidney disease—a challenge for all ages. JAMA. 2012 Dec 12;308(22):2401-2. doi: 10.1001/jama.2012.30761

4. Farrington K, Covic A, Nistor I, Aucella F, Clyne N, De Vos L, Findlay A, Fouque D, Grodzicki T, Iyasere O, Jager KJ, Joosten H, Macias JF, Mooney A, Nagler E, Nitsch D, Taal M, Tattersall J, Stryckers M, van Asselt D, Van den Noortgate N, van der Veer S, van Biesen W. Clinical Practice Guideline on management of older patients with chronic kidney disease stage 3b or higher (eGFR<45 mL/min/1.73 m 2 ): a summary document from the European Renal Best Practice Group. Nephrol Dial Transplant. 2017 Jan 1;32(1):9-16. doi: 10.1093/ndt/gfw411

5. Delanaye P, Schaeffner E, Cozzolino M, Langlois M, Plebani M, Ozben T, Cavalier E. The new, race-free, Chronic Kidney Disease Epidemiology Consortium (CKD-EPI) equation to estimate glomerular filtration rate: is it applicable in Europe? A position statement by the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM). Clin Chem Lab Med. 2022 Oct 24;61(1):44-47. doi: 10.1515/cclm-2022-0928

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3